title,subsection,type,main_content,context,outcome
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q1,To characterize the impact of lung adenocarcinoma growth on myelopoiesis,(missing),"we profiled progenitors and myeloid lineages in BM of naive and KrasLSL-G12D/+;Trp53fl/fl (KP) tumour-bearing mice modelling non-small-cell lung cancer (NSCLC), at early (day 7), middle (day 15) and advanced (day 21) time points"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"We observed a marked increase in long-term haematopoietic stem cells (LT-HSC), multipotent common myeloid progenitors (CMP), granulocytic–monocytic progenitors (GMP) and committed monocyte progenitor (cMoP) by flow cytometry in BM of advanced KP tumour-bearing mice (Fig. 1a) alongside an increase in more mature myeloid populations (Extended Data Figs. 1a and 2a)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"BM progenitors from late-stage tumour-bearing mice formed markedly more granulocytic–monocytic colonies than erythroid colonies and proliferated more than their tumour-naive counterparts (Extended Data Fig. 1b,c)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"In addition, we observed an increased mobilization of Ly6Chi monocytes and Ly6Ghi neutrophils in circulation tracking with tumour burden (Extended Data Figs. 1d and 2b)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,We also observed an expansion of GMP-derived CD157+Ly6Chi neutrophil-like monocytes in the BM and peripheral blood of late-stage tumour-bearing mice (Fig. 1b),"previously described to expand in emergency conditions and engender oxidative burst-associated degranulation gene programs (Ref: 9,10)",(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"We observed a similar expansion of GMPs, cMoPs and CD157+Ly6Chi monocytes in the KrasLSL-G12D/+;Trp53fl/fl genetically engineered mouse model (GEMM) (Extended Data Fig. 1e) and ruled out any contribution of bone metastases (Extended Data Fig. 2c)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q1,we probed how molecular programs are transcriptionally and epigenetically rewired in myeloid progenitors in response to peripheral tumour cues,Given that such myeloid expansion is driven by malignancy,"Experimentally, we used single-cell RNA sequencing (scRNA-seq) to interrogate myeloid progenitor lineages broadly sorted from the BM of age-matched naive and advanced tumour-bearing mice (Extended Data Fig. 2d)"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"We identified distinct granulocytic (granulocytic progenitor, pre-neutrophil, immature neutrophil) and monocytic (cMoP, Ly6Chi monocyte, Ly6Clow monocyte) lineages (Extended Data Fig. 1f and Supplementary Table 2)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q1,(missing),because they are the main source of suppressive mo-macs in tumours (Ref: 11),We focused on monocytic lineage progenitors (GMP and cMoP)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"Differentially upregulated genes in tumour-educated GMPs and cMoPs were associated with biological processes such as ‘response to reactive oxygen species (ROS)’, ‘hypoxia response’, ‘regulation of apoptosis’ and ‘metabolic regulation of superoxide generation’","which was supported in other datasets of tumour-driven myelopoiesis (Ref: 12,13) (Extended Data Fig. 1g,h)",(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"Tumour-associated BM myeloid progenitors and Ly6Chi monocytes also had higher gene signature scores for oxidative stress response and ER stress response (Fig. 1c and Supplementary Table 1) while exhibiting increased cellular ROS burden, lipid peroxidation and mitochondrial oxidative stress as measured by flow cytometry (Fig. 1d)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q1,(missing),(missing),"Using scRNA-seq profiles of myeloid cells with paired small-cell ATAC sequencing (scATAC-seq) data, we then correlated gene programs in each myeloid cell state to chromatin accessibility (Extended Data Fig. 1i) and focused on transcription factors (TF) driving downstream gene programs"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"Lineage-determining TF motifs enriched in GMP marker regions included GATA2, TAL1 and LYL1 (Ref: 14), whereas cMoPs and monocyte marker regions were enriched in IRF4 and SPIB (Ref: 15) (Extended Data Fig. 1j)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q1,We then sought to identify TF motifs enriched in differentially accessible regions of tumour-associated cell states,(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"tumour-associated GMPs and cMoPs had increased motif accessibility for oxidative stress-responsive TFs such as NFE2L2, BACH1, FOSL2, ATF4, ATF5, NFIL3, STAT3 and XBP1 (Ref: 16), AP-1 factors such as JUND, JUN and FOS, and granulocytic fate regulators CEBPB and CEBPA (Ref: 17) (Fig. 1e), when compared with naive counterparts",In line with our transcriptional results,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"H3K4me3 signal (enriched proximal to promoter regions) was gained in tumour-associated myeloid progenitors in genomic regions associated with oxidative stress handling, detoxification, chromatin remodelling and proliferation (Fig. 1f and Extended Data Fig. 1k)",These observations were further supported by our analysis of histone CUT&RUN data,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"Enhancer-associated H3K4me1 and H3K27ac signal augmented in tumour-associated GMPs was associated with pathways involved in cellular detoxification, immunoregulation and anti-apoptotic or pro-survival pathways (Extended Data Fig. 1l)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"Domains of regulatory chromatin (DORC) scores calculated on H3K4me3 signal–gene association highlighted genes involved in inflammation regulation (for example, S100a8, S100a9, Hif1a, Chil3, Lcn2 and Prtn3), metabolic adaptation under oxidative stress (for example, Hk3, Eif5a, Pkm, Gpi1, Gsr and Aldh2) and mitogen-induced survival (for example, Anxa3, Tnfrsf1a and Serpinb1a) activated in KP-experienced GMPs (Fig. 1g and Methods)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,we observed a reduction of type I or III interferon (IFN)-stimulated gene expression in tumour-associated BM myeloid progenitors,(missing),"supporting a dampened inflammatory state (Ref: 18,19) distal to the TME (Fig. 1c)"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"The reduced chromatin accessibility for several IFN pathway TFs including IRF3, IRF7, IRF5 and STAT2 (Fig. 1e), lower H3K4me3-associated DORC scores at IFN-stimulated gene (ISG) loci such as Ifi203, Oasl1 and Isg15 (Fig. 1g) and lower H3K4me1-associated and H3K27ac-associated DORC scores complemented by higher H3K27me3 repressive histone mark at gene loci such as Ifitm3, Ms4a4c, Mx1 and Gbp4 in tumoural BM myeloid progenitors (Extended Data Fig. 1m)",(missing),further supported our transcriptomic findings of IFN hyposensitivity
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"We identified certain binding motifs for TFs such as Nfe2l2 to be enriched in promoter-proximal activating histone marks of tumoural myeloid progenitors, unlike TFs such as Gata2, Mesp1, Glis2 and Tcf3 that are enriched at more distal H3K4me1 and H3K27ac enhancer-associated signal (Extended Data Fig. 1n)",(missing),"These results collectively suggested that tumour-associated myelopoiesis drives priming of pathways in BM GMPs involved in the ROS stress response (Ref: 20), mitochondria–ER metabolic adaptations (Ref: 21) and IFN hypo-responsiveness to limit exhaustion (Ref: 22)"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"found that HSCs, multipotent progenitors (MPPs) and GMPs were elevated in peripheral blood from patients with early-stage NSCLC when compared with healthy donors (Fig. 1h and Extended Data Fig. 2e)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q1,to interrogate molecular changes,(missing),We next conducted a 10x Multiome (RNA + ATAC) assay on peripheral blood mononuclear cells (PBMCs) from patients with NSCLC
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"CD14+ monocytes from peripheral blood of patients with early NSCLC had increased oxidative stress response signature scores (Fig. 1i and Extended Data Fig. 1o) and accessible chromatin topics enriched in these patients were associated with ‘MAPK signalling activation’, ‘metabolic processes’, ‘response to ROS’ and ‘response to oxidative stress’ (Fig. 1j and Extended Data Fig. 1p)",Mirroring our findings in mice,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NSCLC influences chromatin state of BM progenitors,Q2,"genes differentially expressed in monocytes from patients with NSCLC were downstream of TF regulators such as NFE2L2, STAT3, PPARG and MYC (Extended Data Fig. 1q)",(missing),"Thus, cancer-associated inflammation provokes demand-adapted mobilization of myeloid-biased progenitors associated with oxidative stress-responsive epigenomic remodelling"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q1,To measure whether imprinting of stress-responsive programs in BM myeloid progenitors upon sensing systemic tumour cues influence mo-mac states in the TME,(missing),we adoptively transferred GMPs from either tumour-bearing mice or naive mice into a tumour-bearing congenic host (Extended Data Fig. 2f)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"We found mo-macs derived from tumour-primed GMPs to be more immunoregulatory in the TME, characterized by increased differentiation into GPNMB+CD9+TREM2hi mo-macs (Ref: 23) expressing higher PD-L1, increased ARG1+ mo-macs (Ref: 24) and decreased frequency of CD86+MHCII+ immunostimulatory mo-macs (Fig. 2a and Extended Data Fig. 3a–c)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q1,(missing),In addition,we differentiated BM-derived macrophage (BMDM) ex vivo in the presence of tumour conditioning (CM) either early or later during the differentiation
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,Early exposure to tumour inflammatory cues significantly enhanced mo-mac suppressive phenotype compared with late exposure (Extended Data Fig. 3d),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,Transient incubation of BM progenitors with KP CM also cued a more immunoregulatory phenotype in progeny macrophages (Extended Data Fig. 3e),(missing),These results collectively suggest that exposure of myeloid progenitors to tumour cues affected their ultimate trajectory in the TME
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"Using gene–gene correlation, we identified a module of genes implicated in anti-apoptotic cytoprotection, glycolytic metabolic shift and regulation of oxidative stress that was highly enriched in tumour-infiltrating ARG1hi mo-macs and TREM2hi mo-macs (Extended Data Fig. 4b, Supplementary Table 2 and Methods), regulated by TFs such as STAT3, NFE2L2, HIF1A, KLF4, SPI1 and CEBPB",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"TFs for oxidative stress response, including Nfe2l2, Fosl2 and Bach1, were specifically enriched in tumour-dominant ARG1hi and TREM2hi mo-macs",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"Phenotypically, Ly6Chi monocytes infiltrating KP tumours exhibited a higher oxidative stress burden (Extended Data Fig. 3f) and intratumoural TREM2hi mo-macs had relatively higher amounts of cytosolic ROS when compared with immunostimulatory mo-macs (Extended Data Fig. 3g)",In light of our findings in BM myeloid progenitors,these results suggested that oxidative stress-induced cytoprotective chromatin changes initiated in tumour-educated myeloid progenitors are maintained in tumoural mo-macs
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q1,(missing),(missing),We simultaneously used paired single-cell chromatin accessibility and gene expression profiling to analyse tumour-infiltrating immune cells isolated from 14 human NSCLC lesions (Supplementary Table 3)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"we observed motifs for TFs such as NFE2L2, FOSL2, JUN and BACH1 to be enriched in marker peaks of tumour-infiltrating activated CD14+ monocytes, mo-mac_transition and TREM2hi mo-macs (Extended Data Fig. 4h)",In close agreement with our mouse analyses,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q1,we prioritized TF regulators with sustained cell-type-specific activity in TME-infiltrating immunosuppressive mo-macs,(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"Putative TF regulators in our mouse dataset included Spi1, Mafb and Cebpb, as well as NF-κB or Rel family members and AP-1 family members",associated with response to inflammation and growth factors (Ref: 27) (Extended Data Fig. 4i),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"we again observed a nexus of stress-responsive TFs, principally Nfe2l2, Bach1, Fosl2, Mafk and Mafg",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"Concurrent analyses in our human NSCLC dataset of TME monocytes and mo-macs indicated very similar candidate regulators such as NFKB1, REL, SPIB and CEBPB but also oxidative stress response and integrated stress response regulators NFE2L2, BACH1, MAFF, FOSL2 and ATF4 (Fig. 2b)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour-induced myelopoiesis fuels TME mo-macs,Q2,"Downstream pathways conserved across mouse and human TME mo-macs included ‘heme signalling’, ‘cytoprotection by HMOX1’, ‘response to ER stress’ and ‘mitochondrial biogenesis’ (Extended Data Fig. 4j) and ranking on the basis of correlation to gene expression prioritized NFKB1, REL, CEBPB, CEBPG and NFE2L2 (Fig. 2c)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q1,We were especially interested in NRF2,"because of its role in driving antioxidant gene batteries, promoting resistance to lipid-associated ferroptosis and opposing NF-κB pro-inflammatory cascades (Ref: 28,29). NRF2 can also directly influence pro-inflammatory signals by suppressing type I IFN pathway genes and limiting inflammasome activation (Ref: 30-33)",(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,we observed relative TF motif deviation for NRF2 and aggregate score for NRF2 downstream gene activation to be highest in immunoregulatory ARG1hi and TREM2hi mo-macs that accumulate in late-stage tumours (Ref: 34) (Fig. 2d),In the lung,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q1,(missing),"We did not rely on Nfe2l2 gene expression alone, because NRF2 is regulated post-transcriptionally and post-translationally","As a proxy for activation of NRF2 programs in vivo, we assayed the amounts of nuclear NRF2 and intracellular heme oxygenase (HO-1, encoded by Hmox1) (Ref: 35)"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"TREM2hi mo-macs had increased amounts of NRF2 and HO-1 compared with CD86+MHCII+ mo-macs in KP tumours (Extended Data Fig. 3h), and mo-macs in KP GEMM also had increased amounts of NRF2 (Extended Data Fig. 5a)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"in human NSCLC, NRF2 TF motif deviation was highest in immunosuppressive TREM2hi mo-macs and recently infiltrated monocytes (mo-mac_transition), with concomitantly high NRF2 downstream gene activation (Fig. 2e)",Similarly,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"we found the NRF2 activation score to be highest in tumour-associated TREM2hi mo-macs across two independent scRNA-seq datasets (Ref: 36,37) (Extended Data Fig. 3i and Methods)",Furthermore,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q1,we next explored when NRF2 was activated during GMP differentiation to monocytes and mo-macs,Given the persistent NRF2 pathway activation in TME immunosuppressive mo-macs,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"We observed increased NRF2 activation and HO-1 induction in mo-macs that differentiate in vivo from adoptively transferred tumour-experienced BM GMPs, and myeloid progenitors exposed to early transient tumour conditioning (Extended Data Fig. 3j,k)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"GMPs isolated from KP tumour-bearing mice had increased H3K4me3 promoter-proximal signal at known NRF2 oxidative stress response genes such as Gclm, Alas1, Gsr, Prtn3 and Txnrd1 (Extended Data Fig. 3l), but also key immunosuppressive gene loci such as Cebpb, Ptgs1 (Ref: 38), Inhba (Ref: 39), Lcn2 (Ref: 40) and S100a8 (Ref: 41) (Fig. 2f)",(missing),suggesting imprinting of immunoregulatory programs early in differentiation
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"although we observed tumour-educated BM GMPs and monocytes had increased NRF2 motif accessibility compared with their tumour-free counterparts, this was not matched by activation of downstream gene programs (Extended Data Fig. 5b)",Crucially,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q1,we next tested the temporal relationship of IFN responsiveness with NRF2 activation,Given the downregulation of the IFN-stimulated response in tumour-experienced BM myeloid cells,"For this, we implanted lung tumours in Mx1GFP IFN-sensitive response element reporter mice (Ref: 42)"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,tumour-associated monocytes across tissue compartments and tumoural mo-macs had consistently lower GFP expression than their naive counterparts,(missing),indicating lower IFN responsiveness (Extended Data Fig. 5c)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"there was a stepwise increase in Mx1GFP as monocytes infiltrated the tumour, followed by waning in TME mo-macs concomitant with NRF2 activation (Extended Data Fig. 5c,d)",Strikingly,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,"reduced H3K27ac CUT&RUN marks in KP-experienced GMPs at loci such as Mx1, Ifitm1, Slamf7 and H2-Ab1 (Extended Data Fig. 5e)",(missing),Several ISGs and antigen-presentation-associated gene loci are potentially regulated by NRF2 and partner TFs at distal enhancer loci
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 signalling dampens IFN response in the TME,Q2,(missing),(missing),"These results collectively suggested that exposure of BM myeloid progenitors to tumour cues primes NRF2 response loci and certain immunosuppressive gene loci, which promotes a more immunoregulatory fate for mo-macs in the TME with a dampened type I or III IFN response"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q1,to identify cues that activate NRF2,(missing),Taking a candidate approach
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q2,"we found protein factors to be the dominant trigger in tumour CM (Extended Data Fig. 6a,b)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q2,"factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interleukin 6 were enriched in BM sera, blood sera and tumour CM (Extended Data Fig. 6d–f)",Specifically,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q2,"GM-CSF and interleukin 6 mimicked the impact of tumour CM on myelopoiesis, resulting in NRF2 activation, increased HO-1 expression and increased proliferation (Extended Data Fig. 6g,h)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q2,"The myelopoietic effects of KP CM were ameliorated by incubating progenitors with anti-GM-CSF and anti-interleukin 6 neutralizing antibodies, associated with a reduction in oxidative stress burden (Extended Data Fig. 6i,j)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q2,Although there was a reduction in myeloid expansion and HO-1 expression upon incubating progenitors with KP CM in the presence of ML385—an inhibitor of Nfe2l2 DNA binding and transcriptional activity (Ref: 43) (Extended Data Fig. 6k)—there was an increase in oxidative burden (Extended Data Fig. 6l),(missing),suggestive of stress response uncoupling
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q2,We found that stress-responsive p38 MAPK signalling was induced in KP CM-experienced progenitors (Extended Data Fig. 6m) but was not affected by ML385 (Extended Data Fig. 6n),(missing),this suggested NRF2 pathway activation to be downstream of stress-responsive signal transduction from mitogenic cues such as GM-CSF and interleukin 6
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Tumour cues activate NRF2 in BM progenitors,Q2,"Incubating progenitors with GM-CSF and interleukin 6 in the presence of p38 MAPK inhibitor ameliorated myelopoietic expansion as well as HO-1 expression in conjunction with reducing cellular ROS burden (Extended Data Fig. 6o,p)",(missing),our results indicate that NRF2 activation in BM due to tumour mitogen-induced oxidative stress enables progenitors to continue expanding to meet inflammatory demand (Extended Data Fig. 6q)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q1,we interrogated the functional consequence of NRF2 in tumour-associated myeloid cell survival and immunosuppression,Having established the role of NRF2 in BM myeloid expansion,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,"Exposing BMDMs to tumour CM during the last 24 h of culture (to mimic polarization in the TME) resulted in immunosuppressive gene activation, cytoprotection and IFN response suppression (Extended Data Fig. 7a)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q1,(missing),(missing),we cultured BMDMs from NRF2 constitutive knockout mice (Nfe2l2TKO) or wild-type counterparts in the presence of KP CM
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,"we found that tumour-conditioned Nfe2l2TKO BMDMs had lower relative activation of Arg1, Retnla and Chil3, while concomitantly expressing higher amounts of the ISGs Mx1 and Nos2 (Fig. 3a)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,Adding ML385 at day 6 resulted in a similar phenotype (Extended Data Fig. 7b),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,"tumour-educated Nfe2l2TKO BMDMs exhibited increased ROS burden, lipid peroxidation and mitochondrial stress, and increased sensitivity to cell death (Extended Data Fig. 7c,d)",Remarkably,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,Nfe2l2TKO BMDMs did not exhibit increased cell death at steady state (Extended Data Fig. 7e),(missing),This susceptibility for cell death under redox crisis was specific to tumour condition
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,"Viable tumour-educated Nfe2l2TKO BMDMs had reduced expression of HO-1, ARG1 and PD-L1 with increased expression of MHCII, CD86 and CD40 (Fig. 3b)",(missing),indicating a phenotypic shift towards immunogenicity and antigen presentation
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q1,(missing),(missing),"Next, we generated conditional knockout mice, wherein NRF2 is floxed by Cre recombinase under the Ms4a3 promoter (Nfe2l2ΔMs4a3) restricted to GMPs (Ref: 45), resulting in decreased NRF2 activity"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,"Myelopoiesis, differentiation and monocyte function in these mice were unaltered at the steady state (Extended Data Fig. 7f–i)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q1,(missing),(missing),We adoptively transferred GMPs from CD45.2 Nfe2l2ΔMs4a3 or Nfe2l2fl/fl control BM into congenic CD45.1 hosts bearing KP tumours
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,"GMPs from Nfe2l2ΔMs4a3 mice differentiated into more immunostimulatory CD86+MHCII+ mo-macs and strikingly fewer TREM2hi mo-macs in the lung TME, with the TREM2hi mo-macs having decreased PD-L1 (Fig. 3c)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,"GMPs derived from KP-experienced mice treated with quassinoid NRF2 inhibitor Brusatol (Ref: 46), when similarly transferred into congenic tumour-bearing mice, differentiated into more immunostimulatory mo-macs (Fig. 3d)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 regulates mo-mac function in the TME,Q2,GMPs from tumour-naive mice administered antioxidant N-acetyl cysteine (NAC) differentiated into mo-macs with increased immunosuppressive phenotype (Fig. 3d and Extended Data Fig. 7j),(missing),"Thus, manipulating ROS burden and NRF2 activation in BM GMPs influenced subsequent mo-mac phenotype in the TME"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q1,we interrogated how loss of NRF2 signalling functionally affects myelopoiesis,Considering that peripheral tumours can promote NRF2 priming in BM myeloid progenitors,"To do so, we first administered NRF2 inhibitor ML385 in KP tumour-bearing LSL-TdTomatoMs4a3CreERT2 reporter mice and pulsed with one dose of tamoxifen to trace the fate of recently emigrated GMP-derived cells in the TME"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"NRF2 inhibition resulted in a reduction of TdTomato-labelled intratumoural mo-macs and neutrophils 8 days post-tamoxifen, with a significant reduction in the frequency of TREM2hi mo-macs (Fig. 3e)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q1,(missing),Consequently,we implanted KP tumours orthotopically in Nfe2l2ΔMs4a3 and Nfe2l2fl/fl mice
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,Nfe2l2ΔMs4a3 mice had a significant reduction in KP burden and greater overall survival (Fig. 4a and Extended Data Fig. 8a),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,Similar results were obtained in the LLC1 lung cancer model and the B16-F10 model of melanoma lung metastases (Extended Data Fig. 8b),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q1,(missing),(missing),"We also generated transgenic mice, wherein the Kelch-like ECH-associated protein 1 (KEAP1) locus was floxed under Ms4a3Cre (Keap1ΔMs4a3) resulting in GMP-restricted loss of KEAP1"
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,KP tumours were significantly larger in Keap1ΔMs4a3 mice when compared with littermates (Extended Data Fig. 8c),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q1,We next assessed myelopoiesis in Nfe2l2ΔMs4a3 mice,(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"tumour-bearing Nfe2l2ΔMs4a3 mice had significant contraction of BM CMP, GMP and cMoP numbers (Fig. 4b)","Although NRF2 deletion did not affect steady-state myelopoiesis (Extended Data Fig. 7f,g)",(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Reduced NRF2 in tumoural mo-macs of Nfe2l2ΔMs4a3 mice was associated with a reduction in the number of PD-L1-expressing TREM2hi mo-macs in the TME and a compensatory increase in CD86+MHCII+ immunogenic mo-macs (Fig. 4c,d)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,TREM2hi mo-macs in the TME of Nfe2l2ΔMs4a3 mice were more susceptible to cell death (Extended Data Fig. 8d),(missing),providing rationale for the phenotypic shift in the TME
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"The mo-mac distribution in Keap1ΔMs4a3 mice was tumour-promoting, with more abundant TREM2hi mo-macs in the TME expressing PD-L1 (Extended Data Fig. 8e)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q1,To measure the cell-intrinsic effect of NRF2 activation on myelopoiesis independent of tumour burden differences,(missing),we created mixed-BM chimeras with 1:1 reconstitution of CD45.2 Nfe2l2ΔMs4a3 and CD45.1 Nfe2l2WT mice (Extended Data Fig. 8f)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,We observed decreased expansion of Nfe2l2ΔMs4a3 donor-derived GMPs in BM and lower mobilization of Nfe2l2ΔMs4a3 CD157+Ly6Chi monocytes in peripheral blood (Extended Data Fig. 8g),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Consequently in the lung, TREM2hi mo-macs of Nfe2l2ΔMs4a3 origin were also relatively less abundant, whereas CD86+MHCII+ mo-macs were increased (Extended Data Fig. 8h)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,Integrated scRNA-seq and scATAC-seq on the myeloid progenitor lineages in tumour-bearing Nfe2l2ΔMs4a3 mice and control counterparts (Extended Data Fig. 8i) showed the most differentially expressed genes (DEGs) and differentially accessible regions (DARs) to be in GMPs and monocytic lineages (Extended Data Fig. 8j–l),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"The GMP, cMoP and mature monocyte clusters in BM of Nfe2l2ΔMs4a3 mice had reduced TF motif accessibility for Nfe2l2 and Bach1, Stat3, Myc, Myb, Fosl2 and Atf3","that drive important facets of myeloid differentiation, proliferation and survival (Ref: 47-49) (Fig. 4e and Extended Data Fig. 8m)",(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Type I or III IFN response regulators such as Irf3, Irf5 and Irf9 were enriched in DARs of Nfe2l2ΔMs4a3 mature Ly6Chi monocytes, matched by reduced accessibility for Hnf1a, Etv3 and Etv6 (Ref: 50) (Extended Data Fig. 8m)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"molecular programs in lung-infiltrating myeloid cells were significantly altered in Nfe2l2ΔMs4a3 mice (Extended Data Fig. 8n,o)",Downstream of BM progenitors,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"NRF2 activation scores were decreased in Ly6Chi monocytes from Nfe2l2ΔMs4a3 mice, with a concomitant upshift in IFN-responsive gene scores (Extended Data Fig. 8p)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Specifically, there was relative enrichment of ISGs (Stat1, Rsad2, Ifit2, Isg20, Ifit3b) and antigen presentation genes (H2-Ab1, H2-Aa, Mef2c) in Nfe2l2ΔMs4a3 TME-infiltrative monocytes and mo-macs, with a decrease in sensing pathways (Ier3, Tlr4, Cd38 and C3ar1), immunoregulatory genes (Chil3, Vcan, S100a8, Ngp, Lcn2, Arg1, Ptgs1 and Prtn3) and NRF2-associated cytoprotective genes (Gpx3, Gclm, Tfec and Ednrb) (Fig. 4f and Extended Data Fig. 8q)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q1,To disentangle how NRF2 affects local reprogramming in the TME from how it influences replenishment through myelopoiesis,(missing),we leveraged the tamoxifen-inducible strategy to generate Nfe2l2ΔMs4a3CreERT2 mice and conditionally ablate NRF2 signalling in myeloid precursors before or after tumour exposure
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,Tamoxifen administration from the time of KP tumour implantation (early) in Nfe2l2ΔMs4a3CreERT2 mice resulted in a greater reduction in tumour when compared with tamoxifen administration at later stages of progression (Fig. 4g),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Early attenuation of NRF2 signalling in Nfe2l2ΔMs4a3CreERT2 mice was associated with a decrease in BM GMPs, cMoPs and CD157+Ly6Chi monocytes (Fig. 4h), reduced mobilization of CD157+Ly6Chi monocytes (Fig. 4i), but insignificant changes to neutrophil mobilization and tumoural infiltration (Extended Data Fig. 9a,b)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Early attenuation of NRF2 signalling, as evidenced by reduced nuclear NRF2 in TME mo-macs, was associated with accumulation of more immunostimulatory mo-macs (Fig. 4j,k)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,Reduced myeloid NRF2 signalling was associated with significant infiltration of tumoricidal IFNγ+ natural killer cells into lung tumours (Extended Data Fig. 9c–e),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Effector CD8+ T cells were also more abundant in the tumours of Nfe2l2ΔMs4a3 mice (Extended Data Fig. 9f,g)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,"Depletion of monocytes and mo-macs in KP tumour-bearing NRF2-proficient mice resulted in a clear reduction in tumour burden, signifying the importance of mo-macs in KP progression, but such treatment in Nfe2l2ΔMs4a3 mice saw no additive impact",(missing),suggesting NRF2 activation in mo-macs is crucial to orchestrating immunosuppression (Extended Data Fig. 9h)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,NRF2 enhances immunoregulatory myelopoiesis,Q2,depletion of natural killer cells in tumour-bearing Nfe2l2ΔMs4a3 mice resulted in greater tumour burden,(missing),highlighting the mode of immunoregulation in this model to be predominantly by means of natural killer cell exclusion and suppression (Ref: 34) (Extended Data Fig. 9i)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q1,we interrogated whether myeloid NRF2 influences immunotherapy response,Given the impact of NRF2 activation on mo-macs curtailing anti-tumour natural killer cell and T cell surveillance,(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q2,"In three independent scRNA-seq datasets of immunotherapy or chemotherapy response comparing baseline with post-therapy tissue, tumour-infiltrating mo-macs enriched in non-responders (Extended Data Fig. 10a–c and Methods), as well as circulating CD14+ monocytes in non-responders with stable disease (Extended Data Fig. 10d) had DEGs regulated by TFs such as PPARG, TP63, SMAD4 and NFE2L2",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q1,we tested whether pharmacological inhibition of NRF2 can enhance response to checkpoint blockade,Spurred on by our observations,We administered NRF2 inhibitor Brusatol with or without anti-PD-1 therapy starting at day 9 post-KP tumour implant
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q2,"Combination treatment significantly reduced tumour burden (Fig. 4l), affected myelopoiesis as evidenced by the reduction of CMPs, GMPs and cMoPs (Fig. 4m), and reduced mobilization of CD157+Ly6Chi monocytes (Fig. 4n)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q2,"These systemic changes were associated with a decrease in the abundance of mo-macs, specific decrease in PD-L1+TREM2hi mo-macs and concomitant increase in CD86+MHCII+ mo-macs (Fig. 4o)",(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q2,Combination of Brusatol and anti-PD-1 prolonged survival outcomes beyond benefit derived from anti-PD-1 monotherapy (Extended Data Fig. 10e),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q2,A similar dosing regimen using ML385 in conjunction with anti-PD-1 had similarly improved outcomes (Extended Data Fig. 10f),(missing),(missing)
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q2,administration of Brusatol and anti-PD-1 in Nfe2l2ΔMs4a3Cre mice had no additive impact on anti-tumour immunity (Extended Data Fig. 10g),(missing),We found the efficacy of combination therapy relied on targeting of myeloid NRF2
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours,Targeting myeloid NRF2 potentiates immunotherapy,Q2,"Anti-tumour immunity was associated with a substantial influx of natural killer cells with increased expression of CD69 and tumoricidal IFNγ (Extended Data Fig. 10h), alongside effector CD8+ T cells lacking exhaustion marks, and producing IFNγ and tumour necrosis factor (Extended Data Fig. 10i)",(missing),(missing)
